Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Return on Assets (2021 - 2023)

Historic Return on Assets for Candel Therapeutics (CADL) over the last 3 years, with Q3 2023 value amounting to 0.67%.

  • Candel Therapeutics' Return on Assets fell 2700.0% to 0.67% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.67%, marking a year-over-year decrease of 2700.0%. This contributed to the annual value of 0.42% for FY2022, which is 200.0% down from last year.
  • Latest data reveals that Candel Therapeutics reported Return on Assets of 0.67% as of Q3 2023, which was down 2700.0% from 0.58% recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Return on Assets ranged from a high of 0.28% in Q4 2021 and a low of 0.67% during Q3 2023
  • Moreover, its 3-year median value for Return on Assets was 0.39% (2022), whereas its average is 0.43%.
  • As far as peak fluctuations go, Candel Therapeutics' Return on Assets crashed by -100bps in 2022, and later tumbled by -2700bps in 2023.
  • Quarter analysis of 3 years shows Candel Therapeutics' Return on Assets stood at 0.28% in 2021, then tumbled by -55bps to 0.43% in 2022, then crashed by -54bps to 0.67% in 2023.
  • Its Return on Assets stands at 0.67% for Q3 2023, versus 0.58% for Q2 2023 and 0.49% for Q1 2023.